Optimizing the Management of Chronic Immune-Mediated Inflammatory Diseases

Disclosure: Kilian Eyerich, MD, PhD, has disclosed the following relevant financial relationships:

Served as an advisor or consultant for: AbbVie Inc.; Almirall Hermal GmbH; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb Company; Eli Lilly and Company; Janssen Pharmaceuticals; Leo Pharma; Novartis Pharmaceuticals Corporation; Sanofi; Pfizer Inc.; UCB Pharma, Inc.    

Received grants for clinical research from: AbbVie Inc.; Eli Lilly and Company; Janssen Pharmaceuticals; Leo Pharma; UCB Pharma, Inc.

Owns stock, stock options, or bonds from: Dermagnostix

Disclosure: Laure Gossec, MD, PhD, has disclosed the following relevant financial relationships:

Served as an advisor or consultant for: AbbVie Inc.; Amgen Inc.; Bristol Myers Squibb Company; Eli Lilly and Company; Galapagos; Gilead Sciences, Inc.; GlaxoSmithKline; Janssen Pharmaceuticals; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Samsung Bioepis; Sanofi-Aventis; UCB Pharma, Inc. 

Received grants for clinical research from:  Amgen Inc.; Eli Lilly and Company; Galapagos; Pfizer Inc.; Sandoz 

Disclosure: Iain B. McInnes, FRCP, PhD, has disclosed the following relevant financial relationships:

Served as an advisor or consultant for: AbbVie Inc.; AstraZeneca Pharmaceuticals LP; Bristol Myers Squibb Company; Cabaletta; Causeway; Compugen; Eli Lilly and Company; Gilead Sciences, Inc.; GlaxoSmithKline; Janssen Pharmaceuticals; Moonlake; Novartis Pharmaceuticals Corporation; Sanofi; SciRhom; UCB Pharma, Inc.

Served as a speaker or a member of a speakers bureau for: AbbVie Inc.; UCB Pharma, Inc.

Received grants for clinical research from: Amgen Inc.; AstraZeneca Pharmaceuticals LP; Bristol Myers Squibb Company; Boehringer Ingelheim Pharmaceuticals, Inc.; Eli Lilly and Company; UCB Pharma, Inc.

Owns stock, stock options, or bonds from: Cabaletta; Causeway Therapeutics; Compugen; Evelo; Step Pharma

Disclosure: Tim Raine, MB, BChir, PhD, has disclosed the following relevant financial relationships:

Served as an advisor or consultant for: AbbVie Inc.; Arena Pharmaceuticals, Inc.; Aslan; AstraZeneca Pharmaceuticals LP; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb Company; Ferring Pharmaceuticals; Galapagos; Gilead Sciences, Inc.; GlaxoSmithKline; Heptares; Janssen Pharmaceuticals; LabGenius; Pfizer Inc.; Takeda Pharmaceuticals North America, Inc.; UCB Pharma, Inc.

Received grants for clinical research from: AbbVie Inc.

Disclosure: Bruce Strober, MD, PhD, has disclosed the following relevant financial relationships:

Served as an advisor or consultant for: AbbVie Inc.; Almirall; Amgen Inc.; Arcutis; Arena Pharmaceuticals, Inc.; Aristea; Asana; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb Company; Connect Biopharma; Dermavant Sciences, Inc.; EPI Health; Evelo Biosciences; Immunic Therapeutics; Janssen Pharmaceuticals; Leo Pharma; Maruho; Meiji Seika Pharma; Mindera Health; Novartis Pharmaceuticals Corporation; Ono Pharmaceuticals Co., Ltd.; Pfizer Inc.; Regeneron Pharmaceuticals, Inc.; Sanofi-Genzyme Corporation; Sun Pharmaceutical Industries, Ltd.; UCB Pharma, Inc.; Union Therapeutics; Ventyxbio; vTv Therapeutics

Served as a speaker or a member of a speakers bureau for: AbbVie Inc.; Eli Lilly and Company; Incyte Corporation; Janssen Pharmaceuticals; Regeneron Pharmaceuticals, Inc.; Sanofi-Genzyme Corporation

Received grants for clinical research from: AbbVie Inc.; Cara Therapeutics; Dermavant Sciences, Inc.; Dermira Inc.; Novartis Pharmaceuticals Corporation

Owns stock, stock options, or bonds from: Connect Biopharma; Mindera Health

Disclosure: Séverine Vermeire, MD, PhD, has disclosed the following relevant financial relationships:

Served as an advisor or consultant for: AbbVie Inc.; AbolerIS Pharma; AgomAB; Alimentiv; Arena Pharmaceuticals, Inc.; AstraZeneca Pharmaceuticals LP; Avaxia Biologics; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb Company; Celgene Corporation; CVasThera; Cytokii Pharma; Dr Falk Pharma; Ferring Pharmaceuticals; Galapagos; Genentech, Inc.-Roche Diagnostics; Gilead Sciences, Inc.; GlaxoSmithKline; Hospira, Inc.; Imidomics; Janssen Pharmaceuticals; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Materia Prima; Merck Sharp & Dohme Corp.; MiroBio; Morphc; MRM Health; Mundipharma; Pfizer Inc.; Prodigest; Progenity; Prometheus Laboratories Inc.; Second Genome; Shire; Surrozen; Takeda Pharmaceuticals North America, Inc.; Theravance, Inc.; Tillots Pharma AG; Zealand Pharma

Served as a speaker or a member of a speakers bureau for: AbbVie Inc.; AbolerIS Pharma; AgomAB; Alimentiv; Arena Pharmaceuticals, Inc.; AstraZeneca Pharmaceuticals LP; Avaxia Biologics; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol Myers Squibb Company; Celgene Corporation; CVasThera; Cytokii Pharma; Dr Falk Pharma; Ferring Pharmaceuticals; Galapagos; Genentech, Inc.- Roche Diagnostics; Gilead Sciences, Inc.; GlaxoSmithKline; Hospira, Inc.; Imidomics; Janssen Pharmaceuticals; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Materia Prima; Merck Sharp & Dohme Corp.; MiroBio; Morphc; MRM Health; Mundipharma; Pfizer Inc.; Prodigest; Progenity; Prometheus Laboratories Inc.; Second Genome; Shire; Surrozen; Takeda Pharmaceuticals North America, Inc.; Theravance, Inc.; Tillots Pharma AG; Zealand Pharma

Received grants for clinical research from: AbbVie Inc.; Galapagos; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Pfizer, Inc.; Takeda Pharmaceuticals North America, Inc.